{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:08:42Z","timestamp":1785802122012,"version":"3.56.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr J"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12937-019-0438-2","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T14:04:50Z","timestamp":1550844290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Nutraceutical approach for the management of cardiovascular risk \u2013 a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study"],"prefix":"10.1186","volume":"18","author":[{"given":"Massimiliano","family":"Ruscica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Pavanello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Gandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Macchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Botta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Dall\u2019Orto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Del Puppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bertolotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Bosisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Mombelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare R.","family":"Sirtori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Calabresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2254-8881","authenticated-orcid":false,"given":"Paolo","family":"Magni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,22]]},"reference":[{"key":"438_CR1","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/CIRCRESAHA.117.308903","volume":"121","author":"P Joseph","year":"2017","unstructured":"Joseph P, Leong D, McKee M, Anand SS, Schwalm JD, Teo K, Mente A, Yusuf S. Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors. Circ Res. 2017;121:677\u201394.","journal-title":"Circ Res"},{"key":"438_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11886-017-0848-8","volume":"19","author":"M Sharifi","year":"2017","unstructured":"Sharifi M, Futema M, Nair D, Humphries SE. Genetic architecture of familial Hypercholesterolaemia. Curr Cardiol Rep. 2017;19:44.","journal-title":"Curr Cardiol Rep"},{"key":"438_CR3","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1177\/2047487318770297","volume":"25","author":"GG Backer De","year":"2018","unstructured":"De Backer GG. Prevention of cardiovascular disease: much more is needed. Eur J Prev Cardiol. 2018;25:1083\u20136.","journal-title":"Eur J Prev Cardiol"},{"key":"438_CR4","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","volume":"385","author":"C Cholesterol Treatment Trialists","year":"2015","unstructured":"Cholesterol Treatment Trialists C, Fulcher J, O'Connell R, Voysey M, Emberson J, Blackwell L, Mihaylova B, Simes J, Collins R, Kirby A, et al. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet. 2015;385:1397\u2013405.","journal-title":"Lancet"},{"key":"438_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ejim.2015.01.002","volume":"26","author":"P Magni","year":"2015","unstructured":"Magni P, Macchi C, Morlotti B, Sirtori CR, Ruscica M. Risk identification and possible countermeasures for muscle adverse effects during statin therapy. Eur J Intern Med. 2015;26:82\u20138.","journal-title":"Eur J Intern Med"},{"key":"438_CR6","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1093\/eurheartj\/ehy182","volume":"39","author":"F Mach","year":"2018","unstructured":"Mach F, Ray KK, Wiklund O, Corsini A, Catapano AL, Bruckert E, De Backer G, Hegele RA, Hovingh GK, Jacobson TA, et al. Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract. Eur Heart J. 2018;39:2526\u201339.","journal-title":"Eur Heart J"},{"key":"438_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/clc.22862","volume":"41","author":"NC Ward","year":"2018","unstructured":"Ward NC, Pang J, Ryan JDM, Watts GF. Nutraceuticals in the management of patients with statin-associated muscle symptoms, with a note on real-world experience. Clin Cardiol. 2018;41:159\u201365.","journal-title":"Clin Cardiol"},{"key":"438_CR8","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.amjcard.2017.06.015","volume":"120","author":"G Marazzi","year":"2017","unstructured":"Marazzi G, Campolongo G, Pelliccia F, Quattrino S, Vitale C, Cacciotti L, Massaro R, Volterrani M, Rosano G. Comparison of low-dose statin versus low-dose statin + Armolipid plus in high-intensity statin-intolerant patients with a previous coronary event and percutaneous coronary intervention (ADHERENCE trial). Am J Cardiol. 2017;120:893\u20137.","journal-title":"Am J Cardiol"},{"key":"438_CR9","doi-asserted-by":"publisher","first-page":"965","DOI":"10.5114\/aoms.2017.69326","volume":"13","author":"AFG Cicero","year":"2017","unstructured":"Cicero AFG, Colletti A, Bajraktari G, Descamps O, Djuric DM, Ezhov M, Fras Z, Katsiki N, Langlois M, Latkovskis G, et al. Lipid lowering nutraceuticals in clinical practice: position paper from an international lipid expert panel. Arch Med Sci. 2017;13:965\u20131005.","journal-title":"Arch Med Sci"},{"key":"438_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.phrs.2018.05.015","volume":"134","author":"A Poli","year":"2018","unstructured":"Poli A, Barbagallo CM, Cicero AFG, Corsini A, Manzato E, Trimarco B, Bernini F, Visioli F, Bianchi A, Canzone G, et al. Nutraceuticals and functional foods for the control of plasma cholesterol levels. An intersociety position paper. Pharmacol Res. 2018;134:51\u201360.","journal-title":"Pharmacol Res"},{"key":"438_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.numecd.2016.11.122","volume":"27","author":"M Pirro","year":"2017","unstructured":"Pirro M, Vetrani C, Bianchi C, Mannarino MR, Bernini F, Rivellese AA. Joint position statement on \"nutraceuticals for the treatment of hypercholesterolemia\" of the Italian Society of Diabetology (SID) and of the Italian Society for the Study of arteriosclerosis (SISA). Nutr Metab Cardiovasc Dis. 2017;27:2\u201317.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"438_CR12","doi-asserted-by":"publisher","first-page":"830","DOI":"10.7326\/0003-4819-150-12-200906160-00006","volume":"150","author":"DJ Becker","year":"2009","unstructured":"Becker DJ, Gordon RY, Halbert SC, French B, Morris PB, Rader DJ. Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial. Ann Intern Med. 2009;150:830\u20139 W147-839.","journal-title":"Ann Intern Med"},{"key":"438_CR13","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1042\/CS20180410","volume":"132","author":"M Weis","year":"2018","unstructured":"Weis M. Impact of the gut microbiome in cardiovascular and autoimmune diseases. Clin Sci (Lond). 2018;132:2387\u20139.","journal-title":"Clin Sci (Lond)"},{"key":"438_CR14","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/sj.ejcn.1602910","volume":"63","author":"TA Larkin","year":"2009","unstructured":"Larkin TA, Astheimer LB, Price WE. Dietary combination of soy with a probiotic or prebiotic food significantly reduces total and LDL cholesterol in mildly hypercholesterolaemic subjects. Eur J Clin Nutr. 2009;63:238\u201345.","journal-title":"Eur J Clin Nutr"},{"key":"438_CR15","doi-asserted-by":"publisher","first-page":"e0139795","DOI":"10.1371\/journal.pone.0139795","volume":"10","author":"M Shimizu","year":"2015","unstructured":"Shimizu M, Hashiguchi M, Shiga T, Tamura HO, Mochizuki M. Meta-analysis: effects of probiotic supplementation on lipid profiles in Normal to mildly Hypercholesterolemic individuals. PLoS One. 2015;10:e0139795.","journal-title":"PLoS One"},{"key":"438_CR16","doi-asserted-by":"publisher","first-page":"e9166","DOI":"10.1097\/MD.0000000000009166","volume":"96","author":"J He","year":"2017","unstructured":"He J, Zhang F, Han Y. Effect of probiotics on lipid profiles and blood pressure in patients with type 2 diabetes: a meta-analysis of RCTs. Medicine (Baltimore). 2017;96:e9166.","journal-title":"Medicine (Baltimore)"},{"key":"438_CR17","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1128\/AEM.61.7.2577-2582.1995","volume":"61","author":"J Grill","year":"1995","unstructured":"Grill J, Schneider F, Crociani J, Ballongue J. Purification and characterization of conjugated bile salt hydrolase from Bifidobacterium longum BB536. Appl Environ Microbiol. 1995;61:2577\u201382.","journal-title":"Appl Environ Microbiol"},{"key":"438_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/BF00294629","volume":"31","author":"JP Grill","year":"1995","unstructured":"Grill JP, Manginot-Durr C, Schneider F, Ballongue J. Bifidobacteria and probiotic effects: action of Bifidobacterium species on conjugated bile salts. Curr Microbiol. 1995;31:23\u20137.","journal-title":"Curr Microbiol"},{"key":"438_CR19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1017\/S0022029909990173","volume":"76","author":"S Andrade","year":"2009","unstructured":"Andrade S, Borges N. Effect of fermented milk containing lactobacillus acidophilus and Bifidobacterium longum on plasma lipids of women with normal or moderately elevated cholesterol. J Dairy Res. 2009;76:469\u201374.","journal-title":"J Dairy Res"},{"key":"438_CR20","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1080\/07853890.2016.1188328","volume":"48","author":"M Ruscica","year":"2016","unstructured":"Ruscica M, Ferri N, Macchi C, Meroni M, Lanti C, Ricci C, Maggioni M, Fracanzani AL, Badiali S, Fargion S, et al. Liver fat accumulation is associated with circulating PCSK9. Ann Med. 2016;48:384\u201391.","journal-title":"Ann Med"},{"key":"438_CR21","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/S0022-2275(20)33328-9","volume":"39","author":"M Puppo Del","year":"1998","unstructured":"Del Puppo M, Kienle MG, Petroni ML, Crosignani A, Podda M. Serum 27-hydroxycholesterol in patients with primary biliary cirrhosis suggests alteration of cholesterol catabolism to bile acids via the acidic pathway. J Lipid Res. 1998;39:2477\u201382.","journal-title":"J Lipid Res"},{"key":"438_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jacl.2013.11.003","volume":"8","author":"M Ruscica","year":"2014","unstructured":"Ruscica M, Gomaraschi M, Mombelli G, Macchi C, Bosisio R, Pazzucconi F, Pavanello C, Calabresi L, Arnoldi A, Sirtori CR, Magni P. Nutraceutical approach to moderate cardiometabolic risk: results of a randomized, double-blind and crossover study with Armolipid plus. J Clin Lipidol. 2014;8:61\u20138.","journal-title":"J Clin Lipidol"},{"key":"438_CR23","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task Force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; world heart federation; international atherosclerosis society; and International Association for the Study of obesity. Circulation. 2009;120:1640\u20135.","journal-title":"Circulation"},{"key":"438_CR24","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","volume":"37","author":"AL Catapano","year":"2016","unstructured":"Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, et al. 2016 ESC\/EAS guidelines for the Management of Dyslipidaemias. Eur Heart J. 2016;37:2999\u20133058.","journal-title":"Eur Heart J"},{"key":"438_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2016.08.018","volume":"253","author":"AL Catapano","year":"2016","unstructured":"Authors\/Task Force M, Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, et al. ESC\/EAS guidelines for the Management of Dyslipidaemias: the task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European atherosclerosis society (EAS) developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis. 2016;253:281\u2013344.","journal-title":"Atherosclerosis"},{"key":"438_CR26","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1590\/S0100-879X2012007500118","volume":"45","author":"SH Kasmas","year":"2012","unstructured":"Kasmas SH, Izar MC, Franca CN, Ramos SC, Moreira FT, Helfenstein T, Moreno RA, Borges NC, Figueiredo-Neto AM, Fonseca FA. Differences in synthesis and absorption of cholesterol of two effective lipid-lowering therapies. Braz J Med Biol Res. 2012;45:1095\u2013101.","journal-title":"Braz J Med Biol Res"},{"key":"438_CR27","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1007\/s12325-017-0580-1","volume":"34","author":"AFG Cicero","year":"2017","unstructured":"Cicero AFG, Fogacci F, Bove M, Veronesi M, Rizzo M, Giovannini M, Borghi C. Short-term effects of a combined nutraceutical on lipid level, fatty liver biomarkers, hemodynamic parameters, and estimated cardiovascular disease risk: a double-blind, placebo-controlled randomized clinical trial. Adv Ther. 2017;34:1966\u201375.","journal-title":"Adv Ther"},{"issue":"4","key":"438_CR28","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/ptr.6282","volume":"33","author":"Federica Fogacci","year":"2019","unstructured":"Fogacci F, Grassi D, Rizzo M, Cicero AFG. Metabolic effect of berberine-silymarin association: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. Phytother Res. 2019. https:\/\/doi.org\/10.1002\/ptr.6282 . [Epub ahead of print]","journal-title":"Phytotherapy Research"},{"key":"438_CR29","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","volume":"388","author":"R Collins","year":"2016","unstructured":"Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, Blumenthal R, Danesh J, Smith GD, DeMets D, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016;388:2532\u201361.","journal-title":"Lancet"},{"key":"438_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12937-016-0213-6","volume":"15","author":"T Kullisaar","year":"2016","unstructured":"Kullisaar T, Zilmer K, Salum T, Rehema A, Zilmer M. The use of probiotic L. fermentum ME-3 containing Reg'Activ Cholesterol supplement for 4 weeks has a positive influence on blood lipoprotein profiles and inflammatory cytokines: an open-label preliminary study. Nutr J. 2016;15:93.","journal-title":"Nutr J"},{"issue":"9","key":"438_CR31","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1177\/2047487319831500","volume":"26","author":"C Macchi","year":"2019","unstructured":"Macchi C, Banach M, Corsini A, Sirtori CR, Ferri N, Ruscica M. Changes in circulating pro-protein convertase subtilisin\/kexin type 9 levels \u2013 experimental and clinical approaches with lipid-lowering agents. Eur J Prev Cardiol. 2019 https:\/\/doi.org\/10.1177\/2047487319831500 . [Epub ahead of print].","journal-title":"European Journal of Preventive Cardiology"},{"key":"438_CR32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.phrs.2017.03.023","volume":"120","author":"AA Momtazi","year":"2017","unstructured":"Momtazi AA, Banach M, Pirro M, Katsiki N, Sahebkar A. Regulation of PCSK9 by nutraceuticals. Pharmacol Res. 2017;120:157\u2013169.","journal-title":"Pharmacol Res."},{"key":"438_CR33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12906-015-0576-9","volume":"15","author":"V Verhoeven","year":"2015","unstructured":"Verhoeven V, Van der Auwera A, Van Gaal L, Remmen R, Apers S, Stalpaert M, Wens J, Hermans N. Can red yeast rice and olive extract improve lipid profile and cardiovascular risk in metabolic syndrome?: a double blind, placebo controlled randomized trial. BMC Complement Altern Med. 2015;15:52.","journal-title":"BMC Complement Altern Med"},{"key":"438_CR34","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1161\/01.ATV.12.7.807","volume":"12","author":"MI Uusitupa","year":"1992","unstructured":"Uusitupa MI, Miettinen TA, Happonen P, Ebeling T, Turtola H, Voutilainen E, Pyorala K. Lathosterol and other noncholesterol sterols during treatment of hypercholesterolemia with lovastatin alone and with cholestyramine or guar gum. Arterioscler Thromb. 1992;12:807\u201313.","journal-title":"Arterioscler Thromb"},{"key":"438_CR35","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nrendo.2017.78","volume":"13","author":"E Gasser","year":"2017","unstructured":"Gasser E, Moutos CP, Downes M, Evans RM. FGF1 - a new weapon to control type 2 diabetes mellitus. Nat Rev Endocrinol. 2017;13:599\u2013609.","journal-title":"Nat Rev Endocrinol"},{"key":"438_CR36","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.cmet.2017.09.005","volume":"26","author":"T Lan","year":"2017","unstructured":"Lan T, Morgan DA, Rahmouni K, Sonoda J, Fu X, Burgess SC, Holland WL, Kliewer SA, Mangelsdorf DJ. FGF19, FGF21, and an FGFR1\/beta-klotho-activating antibody act on the nervous system to regulate body weight and Glycemia. Cell Metab. 2017;26:709\u201318 e703.","journal-title":"Cell Metab"}],"updated-by":[{"DOI":"10.1186\/s12937-019-0483-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T00:00:00Z","timestamp":1567987200000}}],"container-title":["Nutrition Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12937-019-0438-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12937-019-0438-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12937-019-0438-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T11:38:27Z","timestamp":1662982707000},"score":1,"resource":{"primary":{"URL":"https:\/\/nutritionj.biomedcentral.com\/articles\/10.1186\/s12937-019-0438-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,22]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["438"],"URL":"https:\/\/doi.org\/10.1186\/s12937-019-0438-2","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12937-019-0483-x","asserted-by":"object"}]},"ISSN":["1475-2891"],"issn-type":[{"value":"1475-2891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,22]]},"assertion":[{"value":"11 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Following publication of the original article [1], the authors reported an error in the affiliation of the third author, Sara Gandini. The correct affiliation should read: Division of Epidemiology and Biostatistics, IEO, European Institute of Oncology IRCCS, Milan, Italy.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of ASST Grande Ospedale Metropolitano Niguarda. A written informed consent was obtained from each subject.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors have read and approved the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"13"}}